Mitsubishi UFJ Capital
Mitsubishi UFJ Capital is a venture capital firm based in Tokyo, with additional offices in Osaka and Nagoya, founded in 1974. It concentrates on seed to development stage and startup investments across healthcare, biotech, information technology, electronics, high technology, life sciences, fintech, ICT, SaaS, and AI sectors. The firm targets opportunities in Japan and with relevance to the Japanese market, and it participates in investment syndication for Japanese investments to support entrepreneurs and innovation within the domestic economy.
https://crunchbase.com/organization/***
https://linkedin.com/company/***
Past deals in Nuclear Energy
RadioNano Therapeutics
Series A in 2024
RadioNano Therapeutics is developing innovative drugs for Boron Neutron Capture Therapy (BNCT), a specialized radiation therapy that uses nuclear reactions between neutrons and boron-10 to destroy cancer cells.
EX-Fusion
Seed Round in 2023
EX-Fusion is focused on developing and operating the world's first laser-powered commercial nuclear fusion reactor, aiming to provide a sustainable energy solution. The company specializes in the manufacture of continuous plasma generators and is involved in laser-plasma research, offering technology and R&D support for fusion systems. By advancing the practical application of laser fusion, EX-Fusion seeks to overcome the challenges often faced by government-funded fusion research, which can be hindered by shifting political priorities and budget constraints. Through its innovative approach, EX-Fusion aims to contribute significantly to the field of clean energy.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.